Liljeblad M, Lundblad A, Påhlsson P
Department of Biomedicine and Surgery, Linköping University, Sweden.
Glycoconj J. 2000 May;17(5):323-9. doi: 10.1023/a:1007169621518.
It is well established that IgG from rheumatoid arthritis (RA) patients are less galactosylated than IgG from normal individuals. Determination of agalacto-IgG may therefore aid in diagnosis and treatment of RA. The decrease in galactosylation of IgG leads to an increase in terminal N-acetylglucosamine residues, which can be detected using a specific lectin from Psathyrella velutina. In the present study IgG from RA and control serum was purified using affinity chromatography. The samples were then, after reduction, analyzed on a BIOCORE 2000 system with immobilized Psathyrella velutina lectin. Using this technique it was possible to discriminate between IgG from RA patients and IgG from control individuals with respect to its content of IgG with terminal N-acetylglucosamine. The affinity biosensor technique makes it possible to detect binding without labeling or using secondary antibodies.
类风湿性关节炎(RA)患者的IgG半乳糖基化程度低于正常个体的IgG,这一点已得到充分证实。因此,测定去半乳糖基化IgG可能有助于RA的诊断和治疗。IgG半乳糖基化程度降低会导致末端N - 乙酰葡萄糖胺残基增加,这可以使用来自绒毛小脆柄菇的特异性凝集素进行检测。在本研究中,通过亲和色谱法纯化了RA血清和对照血清中的IgG。然后,将样品还原后,在配备固定化绒毛小脆柄菇凝集素的BIOCORE 2000系统上进行分析。使用该技术,可以根据其末端N - 乙酰葡萄糖胺的IgG含量区分RA患者的IgG和对照个体的IgG。亲和生物传感器技术使得无需标记或使用二抗即可检测结合。